When.com Web Search

  1. Ads

    related to: importance of cost behaviour analysis in healthcare industry research

Search results

  1. Results From The WOW.Com Content Network
  2. Cost–utility analysis - Wikipedia

    en.wikipedia.org/wiki/Cost–utility_analysis

    Cost–utility analysis. Cost–utility analysis (CUA) is a form of economic analysis used to guide procurement decisions. The most common and well-known application of this analysis is in pharmacoeconomics, especially health technology assessment (HTA).

  3. Health economics - Wikipedia

    en.wikipedia.org/wiki/Health_economics

    e. Health economics is a branch of economics concerned with issues related to efficiency, effectiveness, value and behavior in the production and consumption of health and healthcare. Health economics is important in determining how to improve health outcomes and lifestyle patterns through interactions between individuals, healthcare providers ...

  4. Healthcare Cost and Utilization Project - Wikipedia

    en.wikipedia.org/wiki/Healthcare_Cost_and...

    HCUP Logo. The Healthcare Cost and Utilization Project ( HCUP, pronounced "H-Cup") is a family of healthcare databases and related software tools and products from the United States that is developed through a Federal-State-Industry partnership and sponsored by the Agency for Healthcare Research and Quality (AHRQ).

  5. Cost–benefit analysis - Wikipedia

    en.wikipedia.org/wiki/Cost–benefit_analysis

    Cost–benefit analysis is often used by organizations to appraise the desirability of a given policy. It is an analysis of the expected balance of benefits and costs, including an account of any alternatives and the status quo. CBA helps predict whether the benefits of a policy outweigh its costs (and by how much), relative to other alternatives.

  6. Pharmacoeconomics - Wikipedia

    en.wikipedia.org/wiki/Pharmacoeconomics

    Pharmacoeconomics refers to the scientific discipline that compares the value of one pharmaceutical drug or drug therapy to another. [1][2] It is a sub-discipline of health economics. A pharmacoeconomic study evaluates the cost (expressed in monetary terms) and effects (expressed in terms of monetary value, efficacy or enhanced quality of life ...

  7. Cost-effectiveness analysis - Wikipedia

    en.wikipedia.org/wiki/Cost-effectiveness_analysis

    Cost-effectiveness analysis (CEA) is a form of economic analysis that compares the relative costs and outcomes (effects) of different courses of action. Cost-effectiveness analysis is distinct from cost–benefit analysis, which assigns a monetary value to the measure of effect. [1] Cost-effectiveness analysis is often used in the field of ...

  8. Cost-minimization analysis - Wikipedia

    en.wikipedia.org/wiki/Cost-minimization_analysis

    Cost-minimization is a tool used in pharmacoeconomics to compare the cost per course of treatment when alternative therapies have demonstrably equivalent clinical effectiveness. [ 1 ] Therapeutic equivalence (including adverse reactions, complications and duration of therapy) must be referenced by the author conducting the study and should have ...

  9. Health care quality - Wikipedia

    en.wikipedia.org/wiki/Health_care_quality

    Definition. Health care quality is the degree to which health care services for individuals and populations increase the likelihood of desired health outcomes. [2] Quality of care plays an important role in describing the iron triangle of health care relationships between quality, cost, and accessibility of health care within a community. [3]